327 related articles for article (PubMed ID: 29485079)
21. Correlation of Acute and Late Brainstem Toxicities With Dose-Volume Data for Pediatric Patients With Posterior Fossa Malignancies.
Nanda RH; Ganju RG; Schreibmann E; Chen Z; Zhang C; Jegadeesh N; Cassidy R; Deng C; Eaton BR; Esiashvili N
Int J Radiat Oncol Biol Phys; 2017 Jun; 98(2):360-366. PubMed ID: 28463155
[TBL] [Abstract][Full Text] [Related]
22. Quantifying the risk and dosimetric variables of symptomatic brainstem injury after proton beam radiation in pediatric brain tumors.
Upadhyay R; Liao K; Grosshans DR; McGovern SL; Frances McAleer M; Zaky W; Chintagumpala MM; Mahajan A; Nana Yeboa D; Paulino AC
Neuro Oncol; 2022 Sep; 24(9):1571-1581. PubMed ID: 35157767
[TBL] [Abstract][Full Text] [Related]
23. Comparison of Diffusion Tensor Imaging and Magnetic Resonance Perfusion Imaging in Differentiating Recurrent Brain Neoplasm From Radiation Necrosis.
Masch WR; Wang PI; Chenevert TL; Junck L; Tsien C; Heth JA; Sundgren PC
Acad Radiol; 2016 May; 23(5):569-76. PubMed ID: 26916251
[TBL] [Abstract][Full Text] [Related]
24. Outcomes following proton therapy for pediatric ependymoma.
Indelicato DJ; Bradley JA; Rotondo RL; Nanda RH; Logie N; Sandler ES; Aldana PR; Ranalli NJ; Beier AD; Morris CG; Mendenhall NP
Acta Oncol; 2018 May; 57(5):644-648. PubMed ID: 29239262
[TBL] [Abstract][Full Text] [Related]
25. Prospective Analysis of Radiation-Induced Contrast Enhancement and Health-Related Quality of Life After Proton Therapy for Central Nervous System and Skull Base Tumors.
Lütgendorf-Caucig C; Pelak M; Hug E; Flechl B; Surböck B; Marosi C; Mock U; Zach L; Mardor Y; Furman O; Hentschel H; Gora J; Fossati P; Stock M; Graichen U; Klee S; Georg P
Int J Radiat Oncol Biol Phys; 2024 Apr; 118(5):1206-1216. PubMed ID: 38244874
[TBL] [Abstract][Full Text] [Related]
26. Progression-free survival of children with localized ependymoma treated with intensity-modulated radiation therapy or proton-beam radiation therapy.
Sato M; Gunther JR; Mahajan A; Jo E; Paulino AC; Adesina AM; Jones JY; Ketonen LM; Su JM; Okcu MF; Khatua S; Dauser RC; Whitehead WE; Weinberg J; Chintagumpala MM
Cancer; 2017 Jul; 123(13):2570-2578. PubMed ID: 28267208
[TBL] [Abstract][Full Text] [Related]
27. Risk of Radiation Vasculopathy and Stroke in Pediatric Patients Treated With Proton Therapy for Brain and Skull Base Tumors.
Hall MD; Bradley JA; Rotondo RL; Hanel R; Shah C; Morris CG; Aldana PR; Indelicato DJ
Int J Radiat Oncol Biol Phys; 2018 Jul; 101(4):854-859. PubMed ID: 29730064
[TBL] [Abstract][Full Text] [Related]
28. Association Between Radiation Necrosis and Tumor Biology After Stereotactic Radiosurgery for Brain Metastasis.
Miller JA; Bennett EE; Xiao R; Kotecha R; Chao ST; Vogelbaum MA; Barnett GH; Angelov L; Murphy ES; Yu JS; Ahluwalia MS; Suh JH; Mohammadi AM
Int J Radiat Oncol Biol Phys; 2016 Dec; 96(5):1060-1069. PubMed ID: 27742540
[TBL] [Abstract][Full Text] [Related]
29. Dosimetric Factors Related to Radiation Necrosis After 5-Fraction Radiosurgery for Patients With Resected Brain Metastases.
Tanenbaum DG; Buchwald ZS; Jhaveri J; Schreibmann E; Switchenko JM; Prabhu RS; Chowdhary M; Abugideiri M; Pfister NT; Eaton B; Kahn SE; Olson JJ; Shu HG; Crocker IR; Curran WJ; Patel KR
Pract Radiat Oncol; 2020; 10(1):36-43. PubMed ID: 31586666
[TBL] [Abstract][Full Text] [Related]
30. Volumetric and actuarial analysis of brain necrosis in proton therapy using a novel mixture cure model.
Niyazi M; Niemierko A; Paganetti H; Söhn M; Schapira E; Goldberg S; Adams J; Kim V; Oh KS; Hwang WL; Lu HM; Belka C; Busse PM; Loeffler JS; Shih HA
Radiother Oncol; 2020 Jan; 142():154-161. PubMed ID: 31563411
[TBL] [Abstract][Full Text] [Related]
31. Irradiated volume as a predictor of brain radionecrosis after linear accelerator stereotactic radiosurgery.
Blonigen BJ; Steinmetz RD; Levin L; Lamba MA; Warnick RE; Breneman JC
Int J Radiat Oncol Biol Phys; 2010 Jul; 77(4):996-1001. PubMed ID: 19783374
[TBL] [Abstract][Full Text] [Related]
32. The role of proton beam therapy in central neurocytoma: A single-institution experience.
Kang KH; Schapira E; Niemierko A; Martinez-Lage M; Bussière MR; Yock TI; Loeffler JS; Butler WE; Carter BS; Shih HA
Pract Radiat Oncol; 2018; 8(5):e305-e311. PubMed ID: 29706302
[TBL] [Abstract][Full Text] [Related]
33. Incidence and dosimetric parameters of pediatric brainstem toxicity following proton therapy.
Indelicato DJ; Flampouri S; Rotondo RL; Bradley JA; Morris CG; Aldana PR; Sandler E; Mendenhall NP
Acta Oncol; 2014 Oct; 53(10):1298-304. PubMed ID: 25279957
[TBL] [Abstract][Full Text] [Related]
34. Cerebral radiation necrosis in pediatric patients.
Plimpton SR; Stence N; Hemenway M; Hankinson TC; Foreman N; Liu AK
Pediatr Hematol Oncol; 2015 Feb; 32(1):78-83. PubMed ID: 23647507
[TBL] [Abstract][Full Text] [Related]
35. Imaging changes in very young children with brain tumors treated with proton therapy and chemotherapy.
Sabin ND; Merchant TE; Harreld JH; Patay Z; Klimo P; Qaddoumi I; Armstrong GT; Wright K; Gray J; Indelicato DJ; Gajjar A
AJNR Am J Neuroradiol; 2013 Feb; 34(2):446-50. PubMed ID: 22821924
[TBL] [Abstract][Full Text] [Related]
36. Spot scanning proton therapy for malignancies of the base of skull: treatment planning, acute toxicities, and preliminary clinical outcomes.
Grosshans DR; Zhu XR; Melancon A; Allen PK; Poenisch F; Palmer M; McAleer MF; McGovern SL; Gillin M; DeMonte F; Chang EL; Brown PD; Mahajan A
Int J Radiat Oncol Biol Phys; 2014 Nov; 90(3):540-6. PubMed ID: 25304948
[TBL] [Abstract][Full Text] [Related]
37. Outcomes and acute toxicities of proton therapy for pediatric atypical teratoid/rhabdoid tumor of the central nervous system.
McGovern SL; Okcu MF; Munsell MF; Kumbalasseriyil N; Grosshans DR; McAleer MF; Chintagumpala M; Khatua S; Mahajan A
Int J Radiat Oncol Biol Phys; 2014 Dec; 90(5):1143-52. PubMed ID: 25311260
[TBL] [Abstract][Full Text] [Related]
38. Radiation induced contrast enhancement after proton beam therapy in patients with low grade glioma - How safe are protons?
Harrabi SB; von Nettelbladt B; Gudden C; Adeberg S; Seidensaal K; Bauer J; Bahn E; Mairani A; Alber M; Haberer T; Debus J; Herfarth K
Radiother Oncol; 2022 Feb; 167():211-218. PubMed ID: 34973277
[TBL] [Abstract][Full Text] [Related]
39. Temporal lobe toxicity analysis after proton radiation therapy for skull base tumors.
Pehlivan B; Ares C; Lomax AJ; Stadelmann O; Goitein G; Timmermann B; Schneider RA; Hug EB
Int J Radiat Oncol Biol Phys; 2012 Aug; 83(5):1432-40. PubMed ID: 22349042
[TBL] [Abstract][Full Text] [Related]
40. (18)F-fluoromethylcholine (FCho), (18)F-fluoroethyltyrosine (FET), and (18)F-fluorodeoxyglucose (FDG) for the discrimination between high-grade glioma and radiation necrosis in rats: a PET study.
Bolcaen J; Descamps B; Deblaere K; Boterberg T; De Vos Pharm F; Kalala JP; Van den Broecke C; Decrock E; Leybaert L; Vanhove C; Goethals I
Nucl Med Biol; 2015 Jan; 42(1):38-45. PubMed ID: 25218024
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
